Sterling Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17K | Buy |
2,828
+1,029
| +57% | +$1.15K | ﹤0.01% | 2758 |
|
|
2025
Q1 | $1.42K | Sell |
1,799
-1,601
| -47% | -$1.27K | ﹤0.01% | 2697 |
|
|
2024
Q4 | $5.61K | Buy |
3,400
+3,048
| +866% | +$5.03K | ﹤0.01% | 2420 |
|
|
2024
Q3 | $1.23K | Buy |
+352
| New | +$1.23K | ﹤0.01% | 2425 |
|
|
2015
Q4 | – | Sell |
-29,823
| Closed | -$159K | – | 998 |
|
|
2015
Q3 | $159K | Sell |
29,823
-10,897
| -27% | -$58.1K | ﹤0.01% | 929 |
|
|
2015
Q2 | $263K | Buy |
+40,720
| New | +$263K | ﹤0.01% | 817 |
|